Bridgeway Capital Management’s Adicet Bio ACET Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $550K | Hold |
901,600
| – | – | 0.01% | 761 |
|
|
2025
Q1 | $681K | Sell |
901,600
-125,000
| -12% | -$94.4K | 0.02% | 692 |
|
|
2024
Q4 | $988K | Buy |
1,026,600
+175,000
| +21% | +$168K | 0.02% | 673 |
|
|
2024
Q3 | $1.23M | Buy |
851,600
+660,300
| +345% | +$951K | 0.03% | 632 |
|
|
2024
Q2 | $231K | Buy |
191,300
+61,500
| +47% | +$74.4K | 0.01% | 1024 |
|
|
2024
Q1 | $305K | Buy |
129,800
+75,000
| +137% | +$176K | 0.01% | 1036 |
|
|
2023
Q4 | $104K | Sell |
54,800
-194,400
| -78% | -$367K | ﹤0.01% | 1235 |
|
|
2023
Q3 | $341K | Buy |
+249,200
| New | +$341K | 0.01% | 984 |
|
|
2021
Q3 | – | Sell |
-19,999
| Closed | -$206K | – | 1283 |
|
|
2021
Q2 | $206K | Sell |
19,999
-4,285
| -18% | -$44.1K | ﹤0.01% | 1258 |
|
|
2021
Q1 | $318K | Hold |
24,284
| – | – | 0.01% | 1214 |
|
|
2020
Q4 | $341K | Sell |
24,284
-2
| -0% | -$28 | 0.01% | 1081 |
|
|
2020
Q3 | $289K | Hold |
24,286
| – | – | 0.01% | 1083 |
|
|
2020
Q2 | $366K | Buy |
+24,286
| New | +$366K | 0.01% | 966 |
|
|
2019
Q4 | – | Sell |
-13,571
| Closed | -$840K | – | 1303 |
|
|
2019
Q3 | $840K | Hold |
13,571
| – | – | 0.01% | 774 |
|
|
2019
Q2 | $969K | Hold |
13,571
| – | – | 0.01% | 746 |
|
|
2019
Q1 | $648K | Hold |
13,571
| – | – | 0.01% | 933 |
|
|
2018
Q4 | $819K | Hold |
13,571
| – | – | 0.01% | 810 |
|
|
2018
Q3 | $1.44M | Hold |
13,571
| – | – | 0.01% | 736 |
|
|
2018
Q2 | $869K | Buy |
+13,571
| New | +$869K | 0.01% | 928 |
|